Abstract:Brain metastases account for more than 50 % of intracranial central nervous system tumors. The blood-brain barrier (BBB) is mainly composed of endothelial cells, which exhibit low endocytosis and high efflux pumps. Although they are connected by continuous tight junctions and serve as a protective insulation, the BBB does not prevent the development of brain metastases from non-small cell lung cancer (NSCLC). Improving understanding on the mechanisms underlying the development of brain metastasis and the differential molecular characteristics relative to the primary tumor are therefore key in the treatment of brain metastases. This study evaluated the differential expression of miR-522-3p in NSCLC and brain metastases using the Gene Expression Omnibus database. NSCLC brain metastasis model was constructed to screen for cell lines that demonstrated high potential for brain metastasis; We also observed differential expression of miRNA-522-3p in the paraffin-embedded specimens of non-small cell lung cancer and brain metastases from our hospital. The molecular biological functions of miRNA-522-3p were verified using 5-ethynyl-2'-deoxyuridine (EdU) proliferation assay and Transwell invasion assays. RNA-seq was employed to identify downstream target proteins, and the dual-luciferase reporter assay confirmed Tensin 1 (TNS1), a protein that links the actin cytoskeleton to the extracellular matrix, as the downstream regulatory target protein. In vitro blood-brain barrier models and co-culture models were constructed to further identify the role of miRNA-522-3p and TNS1; the expression of BBB-related proteins (ZO-1 and OLCN) was also identified. In vivo experiments were performed to verify the effects of miRNA-522-3p on the time and incidence of NSCLC brain metastasis. The results showed significantly high expression in GSE51666; consistent results were obtained in brain metastasis cells and paraffin samples. RNA-seq combined with miRNA target protein prediction demonstrated TNS1 to be directly downstream of miR-522-3p and to be associated with cell proliferation and invasion. By regulating ZO-1 and OCLN expression, mi-522-3p/TNS1 may increase tumor cell penetration through the BBB while decreasing its permeability. In vivo, miR-522-3p was further demonstrated to significantly promote the formation of brain metastases. miR-522-3p/TNS1 can affect BBB permeability and encourage the growth of brain metastases by modifying the BBB TJ proteins. This axis offers new therapeutic targets for the prevention of brain metastasis.

CXC Motif Chemokine Receptor Type 4 Disrupts Blood-Brain Barrier and Promotes Brain Metastasis Through Activation of the PI3K/AKT Pathway in Lung Cancer

LRRC4 Inhibits Human Glioblastoma Cells Proliferation, Invasion, and Prommp‐2 Activation by Reducing SDF‐1α/CXCR4‐mediated ERK1/2 and Akt Signaling Pathways

C-X-C Receptor Type 4 Promotes Metastasis by Activating P38 Mitogen-Activated Protein Kinase in Myeloid Differentiation Antigen (Gr-1)-positive Cells

The role of CXCR4 in lung cancer metastasis and its possible mechanism]

Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer

The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways

CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

Effect of CXCL12/CXCR4 on increasing the metastatic potential of non-small cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression.

Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling

Abstract 6370: Assessing the Effect of Blocking CCL2-CCR2 Axis on Breast Cancer Brain Metastasis

[Rnai-Mediated Silencing of CXCR4 Inhibits the Adhesion, Invasion and Tumorigenicity of Acute Monocytic Leukemic Cell Line SHI-1].

ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway

Differential Expression of CXCR4 is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells

C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts

C-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities.

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

AKR1B10 Promotes Brain Metastasis of Lung Cancer Cells in a Multi-Organ Microfluidic Chip Model

CXCR3 As a Molecular Target in Breast Cancer Metastasis: Inhibition of Tumor Cell Migration and Promotion of Host Anti-Tumor Immunity

The CD133<SUP>+</SUP>CXCR4<SUP>+</SUP> Colorectal Tumor Cells Promote Colorectal Cancer Progression by PI3K/AKT Signaling

Acute pancreatitis promotes liver metastasis in a mouse model of pancreatic ductal adenocarcinoma via SDF-1_CXCR4 pathway

MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability